Chargement en cours...
P11.61 Development of a novel preclinical GBM model and therapeutic impact of IRE1 inhibition
Glioblastoma Multiforme (GBM) is the most severe primary brain tumor and represents more than 15% of all brain tumors. Despite an aggressive treatment comprising surgical resection and radio/chemotherapy, patient’s survival post diagnosis remains short with a median overall survival of 15 months. Th...
Enregistré dans:
| Publié dans: | Neuro Oncol |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6796129/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.207 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|